Site Search
Search Results
Lamont Signs into Law Legislation to Remove Barriers to Biomarker Testing
HARTFORD – Yesterday, Gov. Ned Lamont signed into law S.B. 307 An Act Concerning Medicaid Coverage of Biomarker Testing . This legislation will increase Connecticut Medicaid (HUSKY Health) coverage of biomarker testing, a form of precision medicine that enables patients to receive treatments personalized to their specific disease. The following statement can be attributed to Bryte Johnson, Director of Government Relations for the American Cancer Society Cancer Action Network (ACS CAN) in ...
Legislature Prioritizing Removing Barriers to Precision Treatments
... Biomarker testing and precision medicine are helping extend and improve lives by tailoring care and treatment to a person’s specific type of cancer. “Biomarker testing made a huge difference in my life,” said Erin Nielson, a cancer survivor in Bethel, CT. “I was diagnosed with ... that my cancer’s DNA would not benefit from chemotherapy. In previous years, chemotherapy, surgery, and radiation would have been the standard of care for my type of cancer.” This legislation will help address a significant barrier and bring the promise of precision medicine to more people, no matter their race or where they live. Personalized treatments based on a patient’s biomarkers can provide many benefits, including better outcomes, improved quality of life, and, in some cases, like Erin’s, reduced costs from bypassing ...